Systematic Exploration of Small-Molecule Binding via a Large Language Model Trained on Textualized Protein–Ligand Interactions
Abstract
1. Introduction
2. Materials and Methods
2.1. Text Conversion for 3D Binding Prediction
2.2. Validation of Text Conversion Using Tight-Binding Designed Data
2.3. Data Preparation with Tokenization
2.4. Training Data for GPT and BERT LLMs
2.5. Deriving Binding Words and Logits Using the Trained LLM
2.6. Validation of LLMs Using Practical Binding Data
2.7. Cluster Analysis
2.8. Analysis for Biological Function
2.9. Analysis from Applied Interaction Data for Biological Function and Ligand Similarity
2.10. Benchmarking Analysis
3. Results
3.1. Synthetic Language to Represent 3D Protein–Ligand Binding Data and Evaluation
3.2. The Model Preserves the Characteristics of Coexisting Binding Nature
3.3. The 3bmGPT Model Clustered Binding Interactions from Associated Molecular Functions by Distinct Features
3.4. The Method Highlighted Key Structural Elements Crucial for Drug Discovery
3.5. Benchmarking Highlights the Model’s Capacity for Sensitive Target Detection
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hughes, J.P.; Rees, S.S.; Kalindjian, S.B.; Philpott, K.L. Principles of early drug discovery. Br. J. Pharmacol. 2011, 162, 1239–1249. [Google Scholar] [CrossRef]
- Dhakal, A.; McKay, C.; Tanner, J.J.; Cheng, J. Artificial intelligence in the prediction of protein-ligand interactions: Recent advances and future directions. Brief. Bioinform. 2022, 23, bbab476. [Google Scholar] [CrossRef]
- Abramson, J.; Adler, J.; Dunger, J.; Evans, R.; Green, T.; Pritzel, A.; Ronneberger, O.; Willmore, L.; Ballard, A.J.; Bambrick, J.; et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 2024, 630, 493–500. [Google Scholar] [CrossRef]
- Passaro, S.; Corso, G.; Wohlwend, J.; Reveiz, M.; Thaler, S.; Somnath, V.R.; Getz, N.; Portnoi, T.; Roy, J.; Stark, H.; et al. Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction. bioRxiv 2025. Available online: http://www.ncbi.nlm.nih.gov/pubmed/40667369 (accessed on 26 October 2025). [CrossRef] [PubMed]
- Ahdritz, G.; Bouatta, N.; Floristean, C.; Kadyan, S.; Xia, Q.; Gerecke, W.; O’donnell, T.J.; Berenberg, D.; Fisk, I.; Zanichelli, N.; et al. OpenFold: Retraining AlphaFold2 yields new insights into its learning mechanisms and capacity for generalization. Nat. Methods 2024, 21, 1514–1524. [Google Scholar] [CrossRef] [PubMed]
- Masters, M.R.; Mahmoud, A.H.; Lill, M.A. Investigating whether deep learning models for co-folding learn the physics of protein-ligand interactions. Nat. Commun. 2025, 16, 8854. [Google Scholar] [CrossRef]
- Ma, Y.; Chen, X. Deep-Learning vs Physics-Based Docking Tools for Future Coronavirus Pandemics. J. Chem. Inf. Model. 2025, 65, 12006–12013. [Google Scholar] [CrossRef] [PubMed]
- Weininger, D. SMILES, a Chemical Language and Information System 1: Introduction to Methodology and Encoding Rules. J. Chem. Inf. Comput. Sci. 1988, 28, 31–36. [Google Scholar] [CrossRef]
- Lee, K.; Kim, D. In-silico molecular binding prediction for human drug targets using deep neural multi-task learning. Genes 2019, 10, 906. [Google Scholar] [CrossRef]
- Flam-Shepherd, D.; Zhu, K.; Aspuru-Guzik, A. Language models can learn complex molecular distributions. Nat. Commun. 2022, 13, 3293. [Google Scholar] [CrossRef]
- Radford, A.; Wu, J.; Child, R.; Luan, D.; Amodei, D.; Sutskever, I. Language Models are Unsupervised Multitask Learners. Available online: https://github.com/codelucas/newspaper (accessed on 1 September 2023).
- Vaswani, A.; Shazeer, N.; Parmar, N.; Uszkoreit, J.; Jones, L.; Gomez, A.N.; Kaiser, L.; Polosukhin, I. Attention Is All You Need. arXiv 2017. Available online: http://arxiv.org/abs/1706.03762 (accessed on 1 September 2023).
- Devlin, J.; Chang, M.W.; Lee, K.; Toutanova, K. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. arXiv 2018. Available online: http://arxiv.org/abs/1810.04805 (accessed on 30 August 2023).
- Kaddour, J.; Harris, J.; Mozes, M.; Bradley, H.; Raileanu, R.; McHardy, R. Challenges and Applications of Large Language Models. arXiv 2023. Available online: http://arxiv.org/abs/2307.10169 (accessed on 1 June 2024).
- Merk, D.; Friedrich, L.; Grisoni, F.; Schneider, G. De Novo Design of Bioactive Small Molecules by Artificial Intelligence. Mol. Inform. 2018, 37, 1700153. [Google Scholar] [CrossRef]
- Bagal, V.; Aggarwal, R.; Vinod, P.K.; Priyakumar, U.D. MolGPT: Molecular Generation Using a Transformer-Decoder Model. J. Chem. Inf. Model. 2021, 62, 2064–2076. [Google Scholar] [CrossRef] [PubMed]
- Ferruz, N.; Schmidt, S.; Höcker, B. ProtGPT2 is a deep unsupervised language model for protein design. Nat. Commun. 2022, 13, 4348. [Google Scholar] [CrossRef] [PubMed]
- Jones, D.; Kim, H.; Zhang, X.; Zemla, A.; Stevenson, G.; Bennett, W.F.D.; Kirshner, D.; Wong, S.E.; Lightstone, F.C.; Allen, J.E. Improved Protein-Ligand Binding Affinity Prediction with Structure-Based Deep Fusion Inference. J. Chem. Inf. Model. 2021, 61, 1583–1592. [Google Scholar] [CrossRef] [PubMed]
- AEwing, T.J.; Makino, S.; Geoffrey Skillman, A.; Kuntz, I.D. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des. 2001, 15, 411–428. [Google Scholar] [CrossRef]
- Velec, H.F.G.; Gohlke, H.; Klebe, G. DrugScoreCSD-knowledge-based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction. J. Med. Chem. 2005, 48, 6296–6303. [Google Scholar] [CrossRef]
- Wang, R.; Lai, L.; Wang, S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J. Comput. Aided Mol. Des. 2002, 16, 11–26. [Google Scholar] [CrossRef]
- Kabsch, W.; Sander, C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983, 22, 2577–2637. [Google Scholar] [CrossRef]
- Francoeur, P.G.; Masuda, T.; Sunseri, J.; Jia, A.; Iovanisci, R.B.; Snyder, I.; Koes, D.R. Three-dimensional convolutional neural networks and a crossdocked data set for structure-based drug design. J. Chem. Inf. Model. 2020, 60, 4200–4215. [Google Scholar] [CrossRef]
- Kufareva, I.; Ilatovskiy, A.V.; Abagyan, R. Pocketome: An encyclopedia of small-molecule binding sites in 4D. Nucleic Acids Res. 2012, 40, D535–D540. [Google Scholar] [CrossRef]
- McNutt, A.T.; Francoeur, P.; Aggarwal, R.; Masuda, T.; Meli, R.; Ragoza, M.; Sunseri, J.; Koes, D.R. GNINA 1.0: Molecular docking with deep learning. J. Cheminform. 2021, 13, 43. [Google Scholar] [CrossRef]
- Wang, L.; Wu, Y.; Deng, Y.; Kim, B.; Pierce, L.; Krilov, G.; Lupyan, D.; Robinson, S.; Dahlgren, M.K.; Greenwood, J.; et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J. Am. Chem. Soc. 2015, 137, 2695–2703. [Google Scholar] [CrossRef] [PubMed]
- Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235–242. [Google Scholar] [CrossRef] [PubMed]
- Rácz, A.; Bajusz, D.; Héberger, K. Life beyond the Tanimoto coefficient: Similarity measures for interaction fingerprints. J. Cheminform. 2018, 10, 48. [Google Scholar] [CrossRef] [PubMed]
- Guha, R. Journal of Statistical Software Chemical Informatics Functionality in R. 2007. Available online: http://www.jstatsoft.org/ (accessed on 24 November 2023).
- Gaujoux, R.; Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinform. 2010, 11, 367. [Google Scholar] [CrossRef]
- Lauterbach, G. The Path to Successful Wafer-Scale Integration: The Cerebras Story. IEEE Micro 2021, 41, 52–57. [Google Scholar] [CrossRef]
- Chan, W.W.; Wise, S.C.; Kaufman, M.D.; Ahn, Y.M.; Ensinger, C.L.; Haack, T.; Hood, M.M.; Jones, J.; Lord, J.W.; Lu, W.P.; et al. Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036. Cancer Cell 2011, 19, 556–568. [Google Scholar] [CrossRef]
- Traxler, P.; Allegrini, P.R.; Brandt, R.; Brueggen, J.; Cozens, R.; Fabbro, D.; Grosios, K.; Lane, H.A.; McSheehy, P.; Mestan, J. AEE788: A Dual Family Epidermal Growth Factor Receptor/ErbB2 and Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor with Antitumor and Antiangiogenic Activity. Cancer Res. 2004, 64, 4931–4941. [Google Scholar] [CrossRef]
- Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215, 403–410. [Google Scholar] [CrossRef]
- Hao, Y.; Hao, S.; Andersen-Nissen, E.; Mauck, W.M.; Zheng, S.; Butler, A.; Lee, M.J.; Wilk, A.J.; Darby, C.; Zager, M.; et al. Integrated analysis of multimodal single-cell data. Cell 2021, 184, 3573–3587.e29. [Google Scholar] [CrossRef]
- Bateman, A.; Martin, M.J.; Orchard, S.; Magrane, M.; Ahmad, S.; Alpi, E.; Bowler-Barnett, E.H.; Britto, R.; Bye-A-Jee, H.; Cukura, A.; et al. UniProt: The Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023, 51, D523–D531. [Google Scholar]
- Aleksander, S.A.; Balhoff, J.; Carbon, S.; Cherry, J.M.; Drabkin, H.J.; Ebert, D.; Feuermann, M.; Gaudet, P.; Harris, N.L.; Hill, D.P. The Gene Ontology knowledgebase in 2023. Baryshnikova A, editor. Genetics 2023, 224, iyad031. [Google Scholar]
- Thomas, P.D.; Ebert, D.; Muruganujan, A.; Mushayahama, T.; Albou, L.P.; Mi, H. PANTHER: Making genome-scale phylogenetics accessible to all. Protein Sci. 2022, 31, 8–22. [Google Scholar] [CrossRef]
- Wishart, D.S.; Feunang, Y.D.; Guo, A.C.; Lo, E.J.; Marcu, A.; Grant, J.R.; Sajed, T.; Johnson, D.; Li, C.; Sayeeda, Z.; et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 2018, 46, D1074–D1082. [Google Scholar] [CrossRef] [PubMed]
- Konc, J.; Janežič, D. ProBiS-ligands: A web server for prediction of ligands by examination of protein binding sites. Nucleic Acids Res. 2014, 42, W215–W220. [Google Scholar] [CrossRef] [PubMed]
- van Kempen, M.; Kim, S.S.; Tumescheit, C.; Mirdita, M.; Lee, J.; Gilchrist, C.L.M.; Söding, J.; Steinegger, M. Fast and accurate protein structure search with Foldseek. Nat. Biotechnol. 2024, 42, 243–246. [Google Scholar] [CrossRef] [PubMed]
- Kanev, G.K.; de Graaf, C.; Westerman, B.A.; de Esch, I.J.P.; Kooistra, A.J. KLIFS: An overhaul after the first 5 years of supporting kinase research. Nucleic Acids Res. 2021, 49, D562–D569. [Google Scholar] [CrossRef]
- Uribe, M.L.; Marrocco, I.; Yarden, Y. Cancers EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance. Cancers 2021, 13, 2748. [Google Scholar] [CrossRef]
- Paul, M.D.; Grubb, H.N.; Hristova, K. Quantifying the strength of heterointeractions among receptor tyrosine kinases from different subfamilies: Implications for cell signaling. J. Biol. Chem. 2020, 295, 9917–9933. [Google Scholar] [CrossRef]
- Du, Z.; Lovly, C.M. Mechanisms of receptor tyrosine kinase activation in cancer. Mol. Cancer 2018, 17, 58. [Google Scholar] [CrossRef] [PubMed]
- Saturno, G.; Pesenti, M.; Cavazzoli, C.; Rossi, A.; Giusti, A.M.; Gierke, B.; Pawlak, M.; Venturi, M. Expression of serine/threonine protein-kinases and related factors in normal monkey and human retinas: The mechanistic understanding of a CDK2 inhibitor induced retinal toxicity. Toxicol. Pathol. 2007, 35, 972–983. [Google Scholar] [CrossRef] [PubMed]
- Taylor, S.S.; Radzio-Andzelm, E.; Hunter, T. How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase. FASEB J. 1995, 9, 1255–1266. [Google Scholar] [CrossRef] [PubMed]
- Bhullar, K.S.; Lagarón, N.O.; McGowan, E.M.; Parmar, I.; Jha, A.; Hubbard, B.P.; Rupasinghe, H.P.V. Kinase-targeted cancer therapies: Progress, challenges and future directions. Mol. Cancer 2018, 17, 48. [Google Scholar] [CrossRef]
- Bergendahl, L.T.; Marsh, J.A. Functional determinants of protein assembly into homomeric complexes. Sci. Rep. 2017, 7, 4932. [Google Scholar] [CrossRef]
- Abrusán, G.; Marsh, J.A. Ligand Binding Site Structure Influences the Evolution of Protein Complex Function and Topology. Cell Rep. 2018, 22, 3265–3276. [Google Scholar] [CrossRef]
- Tobin, J.F.; Freedman, L.P. Nuclear receptors as drug targets in metabolic diseases: New approaches to therapy. Trends Endocrinol. Metab. 2006, 17, 284–290. [Google Scholar] [CrossRef]
- Chandra, V.; Huang, P.; Hamuro, Y.; Raghuram, S.; Wang, Y.; Burris, T.P.; Rastinejad, F. Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA. Nature 2008, 456, 350–356. [Google Scholar] [CrossRef]
- Weber, I.T.; Agniswamy, J. HIV-1 Protease: Structural perspectives on drug resistance. Viruses 2009, 1, 1110–1136. [Google Scholar] [CrossRef]
- Tzoupis, H.; Leonis, G.; Megariotis, G.; Supuran, C.T.; Mavromoustakos, T.; Papadopoulos, M.G. Dual inhibitors for aspartic proteases HIV-1 PR and renin: Advancements in AIDS-hypertension-diabetes linkage via Molecular dynamics, inhibition assays, and binding free energy calculations. J. Med. Chem. 2012, 55, 5784–5796. [Google Scholar] [CrossRef]
- Espinosa-Cantú, A.; Cruz-Bonilla, E.; Noda-Garcia, L.; DeLuna, A. Multiple Forms of Multifunctional Proteins in Health and Disease. Front. Cell Dev. Biol. 2020, 8, 451. [Google Scholar] [CrossRef]
- Lazennec, G.; Canaple, L.; Saugy, D.; Wahli, W. Activation of Peroxisome Proliferator-Activated Receptors (PPARs) by Their Ligands and Protein Kinase A Activators. Mol. Endocrinol. 2000, 14, 1962–1975. Available online: https://academic.oup.com/mend/article/14/12/1962/2751066 (accessed on 28 August 2023). [CrossRef] [PubMed]
- Yue, S.; Li, Y.; Chen, X.; Wang, J.; Li, M.; Chen, Y.; Wu, D. FGFR-TKI resistance in cancer: Current status and perspectives. J. Hematol. Oncol. 2021, 14, 23. [Google Scholar] [CrossRef] [PubMed]
- Hanan, E.J.; Baumgardner, M.; Bryan, M.C.; Chen, Y.; Eigenbrot, C.; Fan, P.; Gu, X.-H.; La, H.; Malek, S.; Purkey, H.E.; et al. 4-Aminoindazolyl-dihydrofuro[3, 4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase. Bioorganic Med. Chem. Lett. 2016, 26, 534–539. [Google Scholar] [CrossRef]
- Konicek, B.W.; Capen, A.R.; Credille, K.M.; Ebert, P.J.; Falcon, B.L.; Heady, G.L.; Patel, B.K.R.; Peek, V.L.; Stephens, J.R.; Stewart, J.A. Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors. Oncotarget 2018, 9, 13796–13806. [Google Scholar] [CrossRef]
- Huang, W.S.; Liu, S.; Zou, D.; Thomas, M.; Wang, Y.; Zhou, T.; Romero, J.; Kohlmann, A.; Li, F.; Qi, J.; et al. Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase. J. Med. Chem. 2016, 59, 4948–4964. [Google Scholar] [CrossRef]
- Shi, L.; Potts, M.; Kennelly, P.J. The serine, threonine, and/or tyrosine-specific protein kinases and protein phosphatases of prokaryotic organisms: A family portrait. FEMS Microbiol. Rev. 1998, 22, 229–253. [Google Scholar] [CrossRef]
- Laskowski, R.A.; Luscombe, N.M.; Swindells, M.B.; Thornton, J.M.; Thornton, J.M. Protein clefts in molecular recognition and function. Protein Sci. 1996, 5, 2438–2452. [Google Scholar]
- Govindaraj, R.G.; Brylinski, M. Comparative assessment of strategies to identify similar ligand-binding pockets in proteins. BMC Bioinform. 2018, 19, 91. [Google Scholar] [CrossRef]
- Shydlovskyi, S.; Zienert, A.Y.; Ince, S.; Dovengerds, C.; Hohendahl, A.; Dargazanli, J.M.; Blum, A.; Günther, S.D.; Kladt, N.; Stürzl, M.; et al. Nucleotide-dependent farnesyl switch orchestrates polymerization and membrane binding of human guanylate-binding protein. Proc. Natl. Acad. Sci. USA 2017, 114, E5559–E5568. [Google Scholar] [CrossRef]
- Law, B.K.; Nørgaard, P.; Gnudi, L.; Kahn, B.B.; Poulson, H.S.; Moses, H.L. Inhibition of DNA synthesis by a farnesyltransferase inhibitor involves inhibition of the p70(s6k) pathway. J. Biol. Chem. 1999, 274, 4743–4748. [Google Scholar] [CrossRef] [PubMed]
- Berdis, A.J. DNA polymerases as therapeutic targets. Biochemistry 2008, 47, 8253–8260. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.F.; Xiang, L.; Zhou, Q.; Carralot, J.P.; Prunotto, M.; Niederfellner, G.; Pastan, I. Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis. Proc. Natl. Acad. Sci. USA 2016, 113, 10666–10671. [Google Scholar] [CrossRef] [PubMed]
- Quarni, W.; Dutta, R.; Green, R.; Katiri, S.; Patel, B.; Mohapatra, S.S.; Mohapatra, S. Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells. Sci. Rep. 2019, 9, 15202. [Google Scholar] [CrossRef]
- Mishra, B.; Zhang, S.; Zhao, H.; Darzynkiewicz, Z.; Lee, E.Y.C.; Lee, M.Y.W.T.; Zhang, Z. Discovery of a novel DNA polymerase inhibitor and characterization of its antiproliferative properties. Cancer Biol. Ther. 2019, 20, 474–486. [Google Scholar] [CrossRef]
- Zheng, S.; Lei, Z.; Ai, H.; Chen, H.; Deng, D.; Yang, Y. Deep scaffold hopping with multimodal transformer neural networks. J. Cheminform. 2021, 13, 87. [Google Scholar] [CrossRef]
- Xie, L.; Xie, L.; Bourne, P.E. Structure-based systems biology for analyzing off-target binding. Curr. Opin. Struct. Biol. 2011, 21, 189–199. [Google Scholar] [CrossRef]
- Chang, Y.; Wang, X.; Wang, J.; Wu, Y.; Yang, L.; Zhu, K.; Chen, H.; Yi, X.; Wang, C.; Wang, Y. A Survey on Evaluation of Large Language Models. arXiv 2023. Available online: http://arxiv.org/abs/2307.03109 (accessed on 4 September 2023). [CrossRef]






| GPT-2 (Small) | GPT-2 (Medium) | |||
|---|---|---|---|---|
| Word-Based | BPE-Based | Word-Based | BPE-Based | |
| Training time | 2 h | 1 h | 3 h | 2 h |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lee, T.; Jung, H.; Jung, A.; Min, J.; Hong, J.H.; Zhang, B.C.; Jung, J. Systematic Exploration of Small-Molecule Binding via a Large Language Model Trained on Textualized Protein–Ligand Interactions. Molecules 2025, 30, 4516. https://doi.org/10.3390/molecules30234516
Lee T, Jung H, Jung A, Min J, Hong JH, Zhang BC, Jung J. Systematic Exploration of Small-Molecule Binding via a Large Language Model Trained on Textualized Protein–Ligand Interactions. Molecules. 2025; 30(23):4516. https://doi.org/10.3390/molecules30234516
Chicago/Turabian StyleLee, Taeseob, Heehoon Jung, Ahnjae Jung, JaeWoong Min, Jong Hui Hong, Bin Claire Zhang, and Jongsun Jung. 2025. "Systematic Exploration of Small-Molecule Binding via a Large Language Model Trained on Textualized Protein–Ligand Interactions" Molecules 30, no. 23: 4516. https://doi.org/10.3390/molecules30234516
APA StyleLee, T., Jung, H., Jung, A., Min, J., Hong, J. H., Zhang, B. C., & Jung, J. (2025). Systematic Exploration of Small-Molecule Binding via a Large Language Model Trained on Textualized Protein–Ligand Interactions. Molecules, 30(23), 4516. https://doi.org/10.3390/molecules30234516

